Joaquin Duato and Margot Robbie are prominent public figures whose names sometimes appear together in online searches, yet their careers belong to entirely different worlds. Duato built his reputation inside Johnson & Johnson, rising through more than three decades of corporate leadership to become chairman and chief executive officer. Robbie became internationally known as an Australian actor and producer whose work ranges from The Wolf of Wall Street and Harley Quinn to I, Tonya and Barbie.
There is no publicly confirmed family, romantic, professional, or business relationship between Joaquin Duato and Margot Robbie. They have not announced a joint project, appeared in a verified partnership, or identified each other as friends or relatives. The most accurate way to understand the search is therefore to examine their separate lives, achievements, families, finances, and current public roles.
Their stories offer a clear contrast. Duato leads one of the world’s largest healthcare companies, where his decisions affect medicines, medical technology, employees, investors, and patients. Robbie works in entertainment, where she has expanded from acting into film development and production through LuckyChap Entertainment.
Is There a Connection Between Joaquin Duato and Margot Robbie?
No credible public evidence establishes a meaningful connection between Joaquin Duato and Margot Robbie. Duato is known for his work in pharmaceuticals, medical technology, business strategy, and corporate management. Robbie is known for acting, producing, and helping develop film and television projects.
They are not publicly known to share investments, charitable campaigns, relatives, representatives, or employers. There is also no verified indication that Robbie has worked as a spokesperson for Johnson & Johnson or that Duato has financed one of her films.
Their names may have been paired by search engines, automated content pages, or websites combining popular public figures. Search visibility alone does not prove that two people know each other. Until reliable reporting establishes otherwise, they should be treated as unrelated individuals with separate biographies.
Joaquin Duato’s Early Life and Education
Joaquin Duato was born in Spain and holds both Spanish and American citizenship. Johnson & Johnson’s public records listed him as 63 in March 2026, placing his birth around 1962 or early 1963, although the company does not prominently publish a complete date of birth in its executive biography.
He studied business in Europe and the United States. Duato earned an MBA from ESADE in Barcelona and a Master of International Management from Thunderbird School of Global Management in Arizona. His education prepared him for an international career involving markets, finance, operations, healthcare policy, and corporate strategy.
Little detailed information about his childhood, parents, or siblings has been made public. Unlike an actor whose personal history often becomes part of publicity, Duato has kept most of his family background outside the public record. His professional life is well documented, but many private details remain unconfirmed.
Joaquin Duato’s Career at Johnson & Johnson
Duato joined Johnson & Johnson in 1989. His rise was gradual and largely took place inside the same organization, giving him experience across different countries, product categories, and management functions.
Over the years, he held leadership roles in sales, pharmaceuticals, operations, technology, and international business. He later served as worldwide chairman of the pharmaceutical division, executive vice president, and vice chairman of Johnson & Johnson’s executive committee.
Duato became chief executive officer in January 2022. He succeeded Alex Gorsky and became chairman of the board in January 2023. His appointment placed him in charge during a period of major restructuring and increased attention on prescription medicines and medical technology.
His long tenure gave him deep knowledge of Johnson & Johnson’s internal culture and global operations. That experience has been especially important because the company works across highly regulated fields in which product development can take years and failures can carry major financial and human costs.
Reshaping Johnson & Johnson
One of the defining developments of Duato’s leadership was the separation of Johnson & Johnson’s consumer-health business. That operation became Kenvue, the independent company behind brands that had long been associated with Johnson & Johnson’s public identity.
The separation, completed in 2023, left Johnson & Johnson more focused on prescription medicines and medical technology. Its priority areas included oncology, immunology, neuroscience, cardiovascular care, surgery, and vision products.
This change altered how the company should be understood. Johnson & Johnson was no longer primarily a broad collection of medicines, medical devices, and familiar consumer goods. Under Duato, it became more concentrated around healthcare products that require scientific research, clinical testing, regulatory approval, and hospital or physician adoption.
In March 2025, the company announced plans to invest more than $55 billion in United States manufacturing, research, development, and technology over four years. The planned spending reflected both commercial ambitions and the pressure on large healthcare companies to strengthen domestic production.
Later in 2025, Johnson & Johnson announced its intention to separate its DePuy Synthes orthopaedics business. The proposed move was designed to give the remaining medical-technology operation greater focus on faster-growing categories while allowing the orthopaedics company to operate independently. As of 2026, the plan remained subject to execution, regulatory, market, and business risks.
Joaquin Duato’s Public Reputation
Duato is generally presented as a disciplined, internationally experienced corporate leader rather than a celebrity executive. His public appearances usually concern business results, research investment, healthcare access, technology, or company strategy.
He has also received recognition connected to his Spanish heritage and international career. In 2023, King Felipe VI of Spain awarded him the Order of Civil Merit, Commander by Number. He was later named the Spain-U.S. Chamber of Commerce’s 2025 Business Leader of the Year.
His leadership also carries scrutiny. Johnson & Johnson operates in industries affected by patent disputes, product litigation, pricing debates, regulatory reviews, manufacturing challenges, and public concern about healthcare costs. A chief executive in this position is judged not only by revenue and share performance but also by how the company handles patient safety, research decisions, legal exposure, and public trust.
Joaquin Duato’s Family and Private Life
Duato does not share extensive information about his private life in official corporate profiles. Details about his spouse, children, home life, or extended family are not widely documented in authoritative public sources.
Some secondary biography websites publish personal claims, but many do not identify reliable evidence. The responsible approach is to separate his confirmed professional history from private information that he has not chosen to disclose.
His low-profile personal life contrasts with his highly visible business position. Investors can examine his compensation, corporate responsibilities, and board role, but that transparency does not extend to every part of his family or finances.
Joaquin Duato’s Compensation and Net Worth
Johnson & Johnson discloses Duato’s compensation because it is a publicly traded company. The company’s 2026 proxy reported total direct compensation of approximately $27.1 million for 2025. His compensation included salary, incentive pay, and long-term equity-based awards.
That figure should not be confused with net worth. Annual executive compensation does not reveal taxes, debts, investments, stock sales, property, family holdings, or personal spending.
Duato’s exact net worth has not been publicly confirmed. Online estimates may attempt to calculate his fortune from salary and stock ownership, but those figures remain estimates rather than verified financial statements.
Margot Robbie’s Early Life and Family
Margot Elise Robbie was born on July 2, 1990, in Dalby, Queensland, Australia. She was raised in Queensland and spent much of her childhood on the Gold Coast and at her grandparents’ farm.
Her parents are Sarie Kessler, a physiotherapist, and Doug Robbie, a former farm owner and sugarcane businessman. She grew up with siblings and has spoken in interviews about working from a young age and helping support herself before her acting career became established.
Robbie attended Somerset College, where she studied drama. After finishing school, she moved to Melbourne to pursue acting professionally. Her early career required persistence, auditions, small roles, and the willingness to relocate before she had financial security or industry influence.
Margot Robbie’s Career Breakthrough
Robbie’s first major recognition came through the Australian soap opera Neighbours. She played Donna Freedman from 2008 to 2011, becoming familiar to Australian television audiences and earning industry award nominations.
She then moved to the United States and joined the short-lived television drama Pan Am. Although the series lasted only one season, it gave her exposure in the American entertainment industry.
Her international breakthrough arrived in 2013 with Martin Scorsese’s The Wolf of Wall Street. Robbie played Naomi Lapaglia opposite Leonardo DiCaprio, delivering a confident performance that made her one of the film’s most discussed cast members.
The role changed her career quickly. It led to major parts in Focus, The Legend of Tarzan, Whiskey Tango Foxtrot, and Suicide Squad. Her portrayal of Harley Quinn became one of her most recognizable roles and introduced her to a global franchise audience.
Major Roles and Critical Recognition
Robbie avoided being defined entirely by blockbuster work. In 2017, she starred as Tonya Harding in I, Tonya, a dark biographical film that she also helped produce.
Her performance earned an Academy Award nomination for Best Actress, along with recognition from the BAFTA Awards, Golden Globes, and other industry groups. The film showed that she could carry a complex character study while also taking responsibility behind the camera.
She received another acting Academy Award nomination for Bombshell, in which she played a fictional employee at Fox News. Other major credits have included Mary Queen of Scots, Once Upon a Time in Hollywood, Birds of Prey, The Suicide Squad, Amsterdam, and Babylon.
Robbie’s choices have moved between commercial entertainment and character-driven films. Some releases became major hits, while others received mixed reviews or disappointing box-office results. That unevenness is normal for a long film career and does not diminish the range of work she has attempted.
LuckyChap Entertainment and Producing
Robbie co-founded LuckyChap Entertainment with Tom Ackerley, Josey McNamara, and Sophia Kerr. The company became a major part of her professional identity, allowing her to help choose, develop, and produce projects rather than waiting only for acting offers.
LuckyChap’s work has included I, Tonya, Promising Young Woman, Birds of Prey, Maid, Saltburn, and Barbie. Several of these projects centered women as lead characters, writers, or directors, though the company’s output has covered different genres and audiences.
The success of Barbie in 2023 marked the company’s largest commercial achievement. Robbie starred as Barbie and served as a producer, helping bring the project from development to the screen.
The film became a global box-office success and earned an Academy Award nomination for Best Picture. Robbie did not receive a Best Actress nomination for the role, but her Best Picture nomination recognized her work as a producer.
Marriage, Child, and Private Life
Robbie met British filmmaker and producer Tom Ackerley while working on Suite Française in 2013. They married in a private ceremony in Australia in December 2016.
Their relationship is also a business partnership. Ackerley is one of the co-founders of LuckyChap and has worked with Robbie on developing and producing films and television projects.
The couple welcomed their first child, a son, in 2024. They have kept the child’s name and exact birth details private, and those details should not be guessed or repeated from unsupported sources.
Robbie has generally protected her marriage and family life despite intense public attention. She discusses her work more openly than her home life, maintaining a boundary between her public career and private relationships.
Margot Robbie’s Net Worth and Income Sources
Margot Robbie’s exact net worth is not publicly confirmed. Entertainment websites publish estimates, but they often rely on assumed salaries, reported property values, endorsements, and unknown ownership stakes.
Her income likely comes from acting fees, producer compensation, profit participation, brand partnerships, residuals, and her interest in LuckyChap Entertainment. The financial success of Barbie may have produced substantial earnings, but the terms of her contract have not been fully disclosed.
Any precise net-worth number should therefore be treated as an estimate. Robbie is clearly one of the most commercially successful actors and producers of her generation, but private wealth cannot be verified from box-office totals alone.
Recent Work and Current Status
Robbie returned to major screen work after becoming a mother. In 2025, she appeared opposite Colin Farrell in A Big Bold Beautiful Journey, directed by Kogonada. The film received mixed critical responses and did not match the commercial scale of Barbie.
In 2026, she starred as Catherine Earnshaw opposite Jacob Elordi in Emerald Fennell’s adaptation of Wuthering Heights. LuckyChap was also involved in the production, extending Robbie’s working relationship with Fennell after Promising Young Woman and Saltburn.
She was also connected to a planned new Ocean’s film, which she was expected to star in and produce. Announced release dates and production plans can change, but the project reflected her continuing ability to move between acting and producing.
Duato, meanwhile, remained chairman and chief executive of Johnson & Johnson in 2026. His work centered on investment, pharmaceutical growth, medical technology, research, and the proposed separation of the orthopaedics business.
Their current lives reinforce the lack of a shared professional story. One leads a healthcare corporation; the other develops and performs in entertainment projects.
Frequently Asked Questions
Are Joaquin Duato and Margot Robbie related?
No. There is no credible public evidence that Joaquin Duato and Margot Robbie are related by blood or marriage.
Do Joaquin Duato and Margot Robbie work together?
No verified joint project, company, campaign, or investment involving both of them has been publicly announced.
How old is Joaquin Duato?
Johnson & Johnson’s 2026 proxy listed Joaquin Duato as 63. His complete date of birth is not prominently confirmed in the company’s official biography.
How old is Margot Robbie?
Margot Robbie was born on July 2, 1990. She turned 36 in July 2026.
Is Margot Robbie married?
Yes. She has been married to British producer and filmmaker Tom Ackerley since December 2016.
Does Margot Robbie have children?
Yes. Robbie and Ackerley welcomed their first child, a son, in 2024. They have kept his name and exact birth details private.
What are Joaquin Duato and Margot Robbie’s net worths?
Neither person’s exact net worth is publicly confirmed. Duato’s executive compensation is disclosed in company filings, while Robbie’s wealth is commonly estimated from acting, producing, and business income.
Conclusion
Joaquin Duato and Margot Robbie represent two very different forms of modern success. Duato spent decades advancing through a global healthcare company before taking responsibility for its strategy, investments, research priorities, and corporate structure. Robbie built her name through performance and then gained greater control by becoming a producer and company co-founder.
Their lives also show different levels of public exposure. Duato’s compensation and business decisions are documented through corporate filings, while much of his family life remains private. Robbie’s films and public appearances attract worldwide attention, yet she has kept firm boundaries around her marriage and child.
No confirmed relationship connects them. Their names appear together as a search phrase, not as part of a documented personal or professional partnership.
What makes each story matter is not a hidden link but the scale of their individual influence. Duato helps direct a company whose products affect global healthcare, while Robbie helps shape popular films and the projects that reach international audiences.
